Date
Title
View
24 May 17
SYGNIS AG: SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd.
View
11 May 17
SYGNIS AG: SYGNIS AG resolves share price of EUR 1.38 for announced capital increase of up to ten percent of share capital
View
08 May 17
SYGNIS AG: SYGNIS AG plans to acquire profitable Innova Biosciences Ltd. for EUR 8 million in cash and up to 3.5 million shares
View
01 Mar 17
SYGNIS AG announces management changes
View
21 Dec 16
SYGNIS AG acquires profitable life sciences tools company C.B.S. Scientific for US $0.9 million in cash and shares
View
14 Jul 16
SYGNIS AG successfully completes Rights Offering and Private Placement
View
29 Jun 16
SYGNIS AG receives commitment for the purchase of up to 2.7 million shares within the scope of a capital increase to finance the acquistion of Expedeon Holdings Ltd.
View
24 Jun 16
SYGNIS AG announces subscription price for new shares in a capital increase to finance the acquisition of Expedeon Holdings Ltd.
View
09 May 16
SYGNIS AG plans to acquire profitable proteomics player Expedeon Holdings Ltd.
View
10 Dec 15
SYGNIS AG successfully completes Rights Offering and Private Placement
View
17 Nov 15
SYGNIS AG plans to issue new shares to finance further growth and commercialization of proprietary product portfolio
View
19 Jan 15
SYGNIS Achieves Major Milestone with the Global Launch of its first Proprietary Product: TruePrime(TM) Single Cell WGA Kit
View